Literature DB >> 20043962

Endocytic uptake of a large array of HPMA copolymers: Elucidation into the dependence on the physicochemical characteristics.

Jihua Liu1, Hillevi Bauer, Jon Callahan, Pavla Kopecková, Huaizhong Pan, Jindrich Kopecek.   

Abstract

Endocytic uptake and subcellular trafficking of a large array of HPMA (N-(2-hydroxypropyl)methacrylamide) based copolymers possessing positively or negatively charged residues, or hydrophobic groups were evaluated by flow cytometry and living cell confocal microscopy in cultured prostate cancer cells. The degrees of cellular uptake of various copolymer fractions with narrow polydispersities were quantified. The copolymer charge was the predominant physicochemical feature in terms of cellular uptake. Fast and efficient uptake occurred in positively charged copolymers due to non-specific adsorptive endocytosis, whereas slow uptake of negatively charged copolymers was observed. The uptake of copolymers was also molecular weight dependent. The copolymers were internalized into the cells through multiple endocytic pathways: positively charged copolymers robustly engaged clathrin-mediated endocytosis, macropinocytosis and dynamin-dependent endocytosis, while weakly negatively charged copolymers weakly employed these pathways; strongly negatively charged copolymers only mobilized macropinocytosis. HPMA copolymer possessing 4 mol% of moderately hydrophobic functional groups did not show preferential uptake. All copolymers ultimately localized in late endosomes/lysosomes via early endosomes; with varying kinetics among the copolymers. This study indicates that cell entry and subsequent intracellular trafficking of polymeric drug carriers are strongly dependent on the physicochemical characteristics of the nanocarrier, such as charge and molecular weight. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20043962      PMCID: PMC2840071          DOI: 10.1016/j.jconrel.2009.12.022

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  50 in total

1.  Dynasore, a cell-permeable inhibitor of dynamin.

Authors:  Eric Macia; Marcelo Ehrlich; Ramiro Massol; Emmanuel Boucrot; Christian Brunner; Tomas Kirchhausen
Journal:  Dev Cell       Date:  2006-06       Impact factor: 12.270

2.  The LNCaP cell line--a new model for studies on human prostatic carcinoma.

Authors:  J S Horoszewicz; S S Leong; T M Chu; Z L Wajsman; M Friedman; L Papsidero; U Kim; L S Chai; S Kakati; S K Arya; A A Sandberg
Journal:  Prog Clin Biol Res       Date:  1980

3.  Soluble biomedical polymers.

Authors:  J Kopecek
Journal:  Polim Med       Date:  1977

Review 4.  Polymer therapeutics: concepts and applications.

Authors:  Rainer Haag; Felix Kratz
Journal:  Angew Chem Int Ed Engl       Date:  2006-02-13       Impact factor: 15.336

Review 5.  Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers.

Authors:  Matthew Kirkham; Robert G Parton
Journal:  Biochim Biophys Acta       Date:  2005-12-30

6.  Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel.

Authors:  J M Meerum Terwogt; W W ten Bokkel Huinink; J H Schellens; M Schot; I A Mandjes; M G Zurlo; M Rocchetti; H Rosing; F J Koopman; J H Beijnen
Journal:  Anticancer Drugs       Date:  2001-04       Impact factor: 2.248

7.  The use of fluorescence microscopy to define polymer localisation to the late endocytic compartments in cells that are targets for drug delivery.

Authors:  Simon C W Richardson; Kerri-Lee Wallom; Elaine L Ferguson; Samuel P E Deacon; Matthew W Davies; Alison J Powell; Robert C Piper; Ruth Duncan
Journal:  J Control Release       Date:  2008-01-04       Impact factor: 9.776

8.  Microfabricated particles for engineered drug therapies: elucidation into the mechanisms of cellular internalization of PRINT particles.

Authors:  Stephanie E A Gratton; Mary E Napier; Patricia A Ropp; Shaomin Tian; Joseph M DeSimone
Journal:  Pharm Res       Date:  2008-07-01       Impact factor: 4.200

9.  Overexpression of a novel rho family GTPase, RacC, induces unusual actin-based structures and positively affects phagocytosis in Dictyostelium discoideum.

Authors:  D J Seastone; E Lee; J Bush; D Knecht; J Cardelli
Journal:  Mol Biol Cell       Date:  1998-10       Impact factor: 4.138

10.  Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.

Authors:  P A Vasey; S B Kaye; R Morrison; C Twelves; P Wilson; R Duncan; A H Thomson; L S Murray; T E Hilditch; T Murray; S Burtles; D Fraier; E Frigerio; J Cassidy
Journal:  Clin Cancer Res       Date:  1999-01       Impact factor: 12.531

View more
  15 in total

1.  Polyelectrolyte complex optimization for macrophage delivery of redox enzyme nanoparticles.

Authors:  Yuling Zhao; Matthew J Haney; Natalia L Klyachko; Shu Li; Stephanie L Booth; Sheila M Higginbotham; Jocelyn Jones; Matthew C Zimmerman; R Lee Mosley; Alexander V Kabanov; Howard E Gendelman; Elena V Batrakova
Journal:  Nanomedicine (Lond)       Date:  2011-01       Impact factor: 5.307

2.  Comparative Endocytosis Mechanisms and Anticancer Effect of HPMA Copolymer- and PAMAM Dendrimer-MTCP Conjugates for Photodynamic Therapy.

Authors:  Raziye Mohammadpour; Shahrokh Safarian; Brandon Buckway; Hamidreza Ghandehari
Journal:  Macromol Biosci       Date:  2016-10-25       Impact factor: 4.979

3.  Biomaterials and drug delivery: past, present, and future.

Authors:  Jindrich Kopecek
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

4.  The influence of linker length on the properties of cathepsin S cleavable (177)Lu-labeled HPMA copolymers for pancreatic cancer imaging.

Authors:  Wen Shi; Sunny M Ogbomo; Nilesh K Wagh; Zhengyuan Zhou; Yinnong Jia; Susan K Brusnahan; Jered C Garrison
Journal:  Biomaterials       Date:  2014-04-19       Impact factor: 12.479

Review 5.  Design of smart HPMA copolymer-based nanomedicines.

Authors:  Jiyuan Yang; Jindřich Kopeček
Journal:  J Control Release       Date:  2015-10-03       Impact factor: 9.776

6.  Combination cytotoxicity of backbone degradable HPMA copolymer gemcitabine and platinum conjugates toward human ovarian carcinoma cells.

Authors:  Acharaporn Duangjai; Kui Luo; Yan Zhou; Jiyuan Yang; Jindřich Kopeček
Journal:  Eur J Pharm Biopharm       Date:  2013-12-04       Impact factor: 5.571

7.  POLYMERIC BIOMATERIALS AND NANOMEDICINES.

Authors:  Jiyuan Yang; Jindřich Kopeček
Journal:  J Drug Deliv Sci Technol       Date:  2015-12-01       Impact factor: 3.981

8.  Immune-tolerant elastin-like polypeptides (iTEPs) and their application as CTL vaccine carriers.

Authors:  S Cho; S Dong; K N Parent; M Chen
Journal:  J Drug Target       Date:  2015-08-25       Impact factor: 5.121

9.  Efficiency of high molecular weight backbone degradable HPMA copolymer-prostaglandin E1 conjugate in promotion of bone formation in ovariectomized rats.

Authors:  Huaizhong Pan; Monika Sima; Scott C Miller; Pavla Kopečková; Jiyuan Yang; Jindřich Kopeček
Journal:  Biomaterials       Date:  2013-06-02       Impact factor: 12.479

Review 10.  Nanoparticle-mediated drug delivery for treating melanoma.

Authors:  Vaibhav Mundra; Wei Li; Ram I Mahato
Journal:  Nanomedicine (Lond)       Date:  2015-08-05       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.